Global Fixed Income Insights
December 17, 2018
Emerging Markets Look Forward to 2019

Global Fixed Income Insights

Emerging Markets Look Forward to 2019

Emerging Markets Look Forward to 2019

Share Icon

December 17, 2018


After a challenging year for risky assets, in emerging markets (EM) fixed income in particular, we hold a constructive outlook for 2019, driven by attractive valuations, a benign global backdrop of moderate growth/subdued inflation and a U.S. Federal Reserve Bank (Fed) that is likely approaching the end of its tightening cycle. We believe these factors and growing twin deficits in the U.S. limit the scope for material U.S. dollar appreciation, further supporting EM fixed income assets.

Local currency strategies should benefit from already adequately tight monetary policy in key EM economies, and steep yield curves providing investors with excess term premium. Among credit, the JP Morgan Emerging Markets Bond Index Global (EMBIG), a proxy for U.S. dollar external debt, screens as cheap versus both its historical average and traditional comparables such as U.S. high yield. The same holds true for the JP Morgan Corporate Emerging Markets Bond Index (CEMBI), a proxy for U.S. dollar corporate debt, where absolute and relative spreads have sharply underperformed other credit markets such as U.S. and European high yield in 2018, despite generally improving fundamentals that are reflected in a similarly (low) default profile.

A stable-growth/moderate-inflation global backdrop supports EM assets

Our global outlook for 2019 is one of moderation both on the inflation and growth fronts.

Continued monetary policy normalization and declining oil prices underpin our subdued global inflation outlook. We expect a similar picture of anchored and moderate inflation in EM, barring some idiosyncratic cases.

We also envision slowing global growth, primarily in developed markets (DM), on the back of diminished policy support. Meanwhile, EM should reinforce our moderate growth/subdued inflation thesis, mainly driven by weaker Chinese growth. However, there is dispersion within EM: several key countries are starting to recover, and barring negative shocks, should continue their upward march toward potential growth. We thus expect EM-ex-China growth to stage a mild recovery, which may bode well for EM debt assets, as suggested by a historical analysis of EM debt returns as seen in Display 1.

Finally, a context of softening U.S. growth and subdued inflationary pressures, as well as unsteady U.S. stock and housing markets, significantly undermines the case for further Fed hikes beyond current market pricing. Confirmation of our thesis, and its corollary of potential U.S. dollar weakness next year, should bode well for EM assets. Our analysis suggests an overvaluation of the USD in real terms of approximately 10 percent which strengthens our view of a weaker dollar in 2019.

EM-ex-China at recovery stage: good for EM fixed income

To help inform our views on EM debt assets for the year ahead, we examined the historical performance of bonds, rates and stocks in EM at each stage of the business cycle, which we identified as follows: recovery, expansion, slowdown and contraction. Our output gap calculations indicate that EM-ex-China is currently in the recovery stage of the business cycle, and to the extent that historical performance provides useful information about future return potential, the analysis supports our constructive thesis for EM: all EM debt strategies have posted positive returns during the recovery phase, though they have failed to outperform EM equities.

Display 1: EM assets have tended to outperform during the recovery stage
9435371 Web Display 2_v1

The index performance is provided for illustrative purposes only and is not meant to depict the performance of a specific investment. Past performance is no guarantee of future results. See Disclosure section for index definitions.

Source: Morgan Stanley Investment Management, Bloomberg as of September 2018. Note: Quarterly returns from March 1994 to September 2018 for U.S. dollar hard currency bonds and EM equities. For local rates, EM FX and corporate bonds the sample starts March 2003, June 2003 and March 2002 respectively. We use the JP Morgan EMBIG index for U.S. dollar hard currency bonds, the JP Morgan GBI-EM Global Diversified index for local rates, the MSCI Emerging market index for EM Equities, the JP Morgan GBI-EM Global Diversified FX index for EM FX and the JP Morgan Corporate EMBI Broad Diversified Composite Index for Corporates. We include the following countries to estimate the output gap: Brazil, Chile, Colombia, Czech Republic, Colombia, Hungary, Indonesia, India, Mexico, Malaysia, Nigeria, Peru, Philippines, Poland, Romania, Russia, Thailand, Turkey and South Africa.


All metrics agree that EM sovereign spreads offer value

All valuation metrics we reviewed suggest there is value in sovereign spreads: EMBIG spreads look about 50 basis points cheap to their 10-year historical average, and the Bloomberg Barclays U.S. Corporate High Yield Index-EMBIG spread differential is at all-time lows, despite the higher average credit rating of EM spreads. Furthermore, our fair-value sovereign spread model,[1] which relates spreads to fundamental domestic and external variables, suggests that spreads are cheap by about 40 basis points. The model also points to cheapness in Africa and, to a lesser extent, Latin America, while flagging European sovereigns as expensive and Asian spreads as fairly priced. At the country level, we like Indonesia, Ukraine and South Africa (conditional on a positive election outcome), while we remain cautious in Turkey and Mexico.

Value in local rates on high EM-DM real rate gap, steep curves, amid U.S. dollar weakness

EM real rates still look compelling, at 2 percent levels, and similarly the real yield differential with DM remains attractive at ~300 basis points. We expect real rate differentials to remain at elevated levels next year as Fed Fund rates get closer to neutral, other DM Central Banks cautiously remove monetary stimulus, global inflation remains subdued and EM Central Banks keep tight monetary policy stances. In addition, sizable steepness in several EM curves offer attractive opportunities for extending duration (for example, in Peru and Brazil), while we avoid long-duration positions in Mexico, given heightened policy uncertainty.

Valuations in EM corporate debt look favorable relative to default expectations

We see the sharp correction of EM corporate spreads, particularly in high yield, since the turn of 2Q18 as excessive given our assessment of credit fundamentals. Our confidence in EM credit is grounded in improving metrics (credit, management actions, etc.). The improvement has been supported by the behavior of EM corporates since the end of the global financial crisis. These improvements are best illustrated in default expectations, which now look likely to end the year well below the 2.5% forecast we set at the beginning of the year in spite of the rise in idiosyncratic negative developments in countries such as Argentina and Turkey.

Looking ahead to 2019 we view the spread widening of EM high yield as particularly noteworthy given expectations that default rates in EM will likely remain low and in line with U.S. high yield next year. In investment grade credit, we also believe the weakness in spreads is somewhat counterintuitive given fundamental improvements in EM credit quality (which should continue to see upgrades outpace downgrades over the coming 12-18 months), versus in the U.S., where the combination of debt-financed stock buy-backs, and merger and acquisition (M&A) activity may put pressure on credit ratings in 2019.


Risk Considerations

There is no assurance that a Portfolio will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market values of securities owned by the Portfolio will decline and may therefore be less than what you paid for them. Accordingly, you can lose money investing in this Portfolio. Please be aware that this Portfolio may be subject to certain additional risks.

Fixed-income securities are subject to the ability of an issuer to make timely principal and interest payments (credit risk), changes in interest rates (interest-rate risk), the creditworthiness of the issuer and general market liquidity (market risk). In the current rising interest-rate environment, bond prices may fall and may result in periods of volatility and increased portfolio redemptions. Longer-term securities may be more sensitive to interest rate changes. In a declining interest-rate environment, the portfolio may generate less income. Mortgage- and asset-backed securities are sensitive to early prepayment risk and a higher risk of default and may be hard to value and difficult to sell (liquidity risk). They are also subject to credit, market and interest rate risks. Certain U.S. government securities purchased by the Strategy, such as those issued by Fannie Mae and Freddie Mac, are not backed by the full faith and credit of the U.S. It is possible that these issuers will not have the funds to meet their payment obligations in the future. High-yield securities (“junk bonds”) are lower-rated securities that may have a higher degree of credit and liquidity risk. Public bank loans are subject to liquidity risk and the credit risks of lower-rated securities. Foreign securities are subject to currency, political, economic and market risks. The risks of investing in emerging-market countries are greater than risks associated with investments in foreign developed countries. Sovereign debt securities are subject to default risk. Derivative instruments may disproportionately increase losses and have a significant impact on performance. They also may be subject to counterparty, liquidity, valuation, correlation and market risks. Restricted and illiquid securities may be more difficult to sell and value than publicly traded securities (liquidity risk).

Managing Director
Managing Director
Executive Director


1 “Revisiting Our Emerging Market Sovereign Spread Valuation Framework,” Emerging Markets Debt Team, Investment Insight, 2018.


The Bloomberg Barclays U.S. Corporate High Yield Index measures the market of USD-denominated, non-investment grade, fixed-rate, taxable corporate bonds. Securities are classified as high yield if the middle rating of Moody’s, Fitch, and S&P is Ba1/BB+/BB+ or below. The Index excludes emerging market debt.

The JP Morgan Emerging Markets Bond Index Global (EMBIG) tracks total returns for traded external debt instruments in the emerging markets, and is an expanded version of the EMBI+. As with the EMBI+, the EMBI Global includes US dollar-denominated Brady bonds, loans, and Eurobonds with an outstanding face value of at least $500 million.

The JP Morgan GBI-EM Global Diversified Index is a market-capitalization weighted, liquid global benchmark for U.S.-dollar corporate emerging market bonds representing Asia, Latin America, Europe and the Middle East/Africa.

The JP Morgan CEMBI Broad Diversified Index is a global, liquid corporate emerging markets benchmark that tracks U.S.-denominated corporate bonds issued by emerging markets entities.

MSCI Emerging Markets Index (MSCI emerging equities) captures large-and mid-cap representation across 23 emerging markets (EM) countries.


This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA, authorised and regulated by the Financial Conduct Authority. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland Junghofstrasse 13-15 60311 Frankfurt Deutschland (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the U.K., authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich BranchI Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland, Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0)44 588 1074.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.16 percent per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.


A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds.


Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This document should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”), (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.


EMEA: This marketing communication has been issued by Morgan Stanley Investment Management Limited (“MSIM”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy’s/product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

A separately managed account may not be suitable for all investors.

Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing.

The views and opinions are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all investment teams at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

This communication is not a product of Morgan Stanley’s Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This material is a general communication, which is not impartial and has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. All investments involve risks, including the possible loss of principal. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or promoted by the applicable licensor and it shall not have any liability with respect thereto.

MSIM has not authorised financial intermediaries to use and to distribute this document, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person’s circumstances and purpose. MSIM shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary.

This document may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this document in another language, the English version shall prevail.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM’s express written consent.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

All information contained herein is proprietary and is protected under copyright law.

© 2018 Morgan Stanley. All Rights Reserved. 


It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.